“…Pharmaceutical industry also makes investment in research and development (R&D) sector to take competitive advantages over rivals. This industry is considered as high research-intensive, high innovative, well balanced in respect of human intervention and technology, and most importantly it based on intellectual capital for a source of renewal and business performance (DeVol, Wong, Bedroussian, Wallace, Ki, Murphy, & Koepp, 2004;Chen, 2004;Hermans, 2004;Zucker, Darby, & Brewer, 1994;Isaac, Herremans, & Kline, 2010, Khalique, Isa, & Shaari, 2011a. Sharabati et al (2011) argued that a large amount of the existing research on intellectual capital has focused on the developed world particularly within Anglophonic and Scandinavian nations.…”